Golden Ally Lifetech Group, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AQPW research report →
Companywww.signetinternationalholdings.com
Golden Ally Lifetech Group, Inc. , a development stage company, focuses on developing advanced technologies, energy solutions, and medical devices. It focuses on development of bioscience and sport medicines, including Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems.
- CEO
- Oliver Keren Ban
- IPO
- 2007
- Employees
- 10
- HQ
- Austin, TX, US
Price Chart
Valuation
- Market Cap
- $740.86K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.01
- EV/EBITDA
- -0.04
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -772.01%
- ROIC
- -344.65%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-6,071,587 · -10446.44%
- EPS
- $-0.07 · -3872.22%
- Op Income
- $-6,071,587
- FCF YoY
- -3724.14%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.16
- Avg Volume
- 73
Get TickerSpark's AI analysis on AQPW
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AQPW Coverage
We haven't published any research on AQPW yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AQPW Report →